Assessment of inhibin and p53 in granulosa cell tumors of the ovary

Gynecologic Oncology

Volumn 77, Issue 2, 2000, Pages 232-236

  Gebhart, John B ^a   Roche, Patrick C ^a   Keeney, Gary L ^a   Lesnick, Timothy G ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cancer stage; Immunohistochemistry; Neoplasm; Prognosis; Retrospective review

Indexed keywords

INHIBIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0034032021     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5774     Document Type: Article

References (21)

1. Rokitansky C V. Ueber abnormitäten des corpus luteum. Allg Wien Med Ztg. 4:1859;253-261.
2. Stenwig J T, Hazekamp J T, Beecham J B. Granulosa cell tumors of the ovary: A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol. 7:1979;136-152.
3. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol. 52:1994;50-55.
4. Bjorkholm E. Granulosa cell tumors: A comparison of survival in patients and matched controls. Am J Obstet Gynecol. 138:1980;329-331.
5. Evans A T III, Gaffey T A, Malkasian G D Jr, Annegers J F. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 55:1980;231-238.
6. Gurusinghe C J, Healy D L, Jobling T, Mamers P, Burger H G. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol. 57:1995;27-32.
7. Ying S Y. Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 9:1988;267-293.
8. Matzuk M M, Finegold M J, Su J G, Hsueh A J, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319.
9. Lappohn R E, Burger H G, Bouma J, Bangah M, Krans M, de Bruijn H W. Inhibin as a marker for granulosa-cell tumors. N Engl J Med. 321:1989;790-793.
10. Healy D L, Burger H G, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day A J, Rome R, Campbell J J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med. 329:1993;1539-1542.
11. Sluijmer A V, Heineman M J, Evers J L, de Jong F H. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour. Acta Endocrinol. 129:1993;311-314.
12. Jobling T, Mamers P, Healy D L, MacLachlan V, Burger H G, Quinn M, Rome R, Day A J. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol. 55:1994;285-289.
13. Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science. 253:1991;49-53.
14. Marks J R, Davidoff A M, Kerns B J, Humphrey P A, Pence J C, Dodge R K, Clarke-Pearson D L, Iglehart J D, Bast R C Jr, Berchuck A. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 51:1991;2979-2984.
15. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P, Loning T. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer. 64:1995;52-59.
16. Kupryjanczyk J, Thor A D, Beauchamp R, Merritt V, Edgerton S M, Bell D A, Yandell D W. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA. 90:1993;4961-4965.
17. Agresti A. Categorical Data Analysis. 1990;Wiley, New York.
18. Lawless J F. Statistical Models and Methods for Lifetime Data. 1981;Wiley, New York.
19. Liu F S, Ho E S, Lai C R, Chen J T, Shih R T, Yang C H, Tsao C M. Overexpression of p53 is not a feature of ovarian granulosa cell tumors. Gynecol Oncol. 61:1996;50-53.
20. Ala-Fossi S L, Maenpaa J, Aine R, Koivisto P, Koivisto A M, Punnonen R. Prognostic significance of p53 expression in ovarian granulosa cell tumors. Gynecol Oncol. 66:1997;475-479.
21. Inoue M, Fujita M, Enomoto T, Morimoto H, Monden T, Shimano T, Tanizawa O. Immunohistochemical analysis of p53 in gynecologic tumors. Am J Clin Pathol. 102:1994;665-670.